Objective: Chronic inflammatory demyelinating polyradiculopathy (CIDP) is a common, but often misdiagnosed disease of the peripheral nervous system with assumed autoimmune pathogenesis. While current concepts of CIDP postulate a pathogenetic role of B cells and (auto)antibodies, the relevance of CD8 T cells present in the biopsies is still elusive. Thus, we asked whether nervous tissue infiltrating and blood-derived lymphocytes in CIDP are clonally expanded to evaluate the involvement of T cells in the pathogenesis of the disease.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) denominates a group of immune-mediated neuropathies clinically presenting as a mostly symmetric, sensory and motor neuropathy with phases of relapses, remissions, and progression. 1 Although its pathogenesis is not completely understood, CIDP is believed to be of autoimmune origin. Evidence mainly arises from similarities in the clinical presentation of CIDP compared to experimental autoimmune neuritis, 2 spontaneous autoimmune neuropathy observed in NOD B7-2 Ϫ/Ϫ mice, 3 as well as to Guillain-Barré syndrome. 4 Current treatment concepts (corticosteroids, IV immunoglobulins, plasma exchange, anti-CD20) are consistent with a crucial involvement of B-cells and (auto)antibodies in the pathogenesis. 5 Histologic examination of animal models as well as of CIDP tissue revealed the presence of a distinct cellular immune response in terms of lymphocyte and macrophage infiltrates in the endoneurium. 6 -8 Importantly, experimental disease can be induced in mice by transfer of T cells specific for P0 or P2 epitopes, 9, 10 while the administration of antibodies against respective peripheral neuronal epitopes enhances disease severity only when administered together with specific T cells. 11 Further indication for a cellular immune response arises from studies demonstrating activated T cells with increased expression of respective surface markers 12 and of matrix metalloproteinases in affected nervous tissue. 13 Additionally, lymphocytes with subtle signs of activation 14 and reduced numbers of FoxP3ϩ regulatory T cells were described in peripheral blood cells. 15 One earlier study reports the T-cell receptor (TCR) V␤ usage of CIDP T-lymphocyte infiltrates as heterogeneous but perturbated, thereby excluding a superantigen hypothesis. 16 Thus, we asked whether nervous tissueinfiltrating and blood-derived lymphocytes in CIDP are clonally expanded to evaluate the hypothesis of an antigen-driven pathogenesis of the disease.
METHODS Patients and controls. We investigated 25 patients with CIDP. All patients were seen at the Department of Neurology, University of Würzburg, between 2008 and 2010. All underwent sural nerve biopsy for diagnostic reasons. Of these 25 patients, 19 formally fulfilled the INCAT criteria for CIDP 17 ; in 6 cases clinical presentation and course, as well as protein levels of CSF, were typical for CIDP together with the picture of a demyelinating neuritis in the sural nerve biopsy without fully fulfilling the electrophysiologic INCAT criteria. The group consisted of 21 men and 4 women with a median age of 66 years (range 44 -79 years). The median disease duration was 4 years (range 0.3-25 years; table e-1 on the Neurology ® Web site at www.neurology.org).
Standard protocol approvals, registrations, and patient consents.
This study was approved by the local ethics committee of the University Clinic of Würzburg, Germany (Ethik-Kommission der Medizinischen Fakultät der Universität Würzburg, registration number 61/05) and written informed consent was received from all participants. The study complied with the Declaration of Helsinki.
RNA preparation from biopsy material and peripheral blood-derived T cells. Sural nerve biopsy was performed in local anesthesia following standard procedures. 18 Segments of the biopsy samples 3 to 10 mm in length were subjected to RNA isolation after thawing on ice using 1 mL Trizol reagent (Invitrogen) according to the manufacturer's standard protocol. Peripheral blood mononuclear cells (PBMC) were isolated and fractionated to CD4ϩ/CD8ϩ subsets within 4 hours after taking blood as described before. 19 cDNA synthesis. cDNA synthesis from peripheral blood T-cell RNA was performed using standard methods as previously described 20 with standard cDNA synthesis reagents obtained from Applied Biosystems. For each sample 250 ng of RNA was transcribed, using random hexamers and M-MLV reverse transcriptase. For RNA isolated from biopsy samples, a previously published sensitive TCR ␤-chain-specific cDNA primer Cb-RT 21 was used, as well as SuperScript III reverse transcriptase (Invitrogen), according to the manufacturer's instructions. CDR3 spectratyping. Spectratyping was performed essentially as described before 19 using a common V␤ nomenclature. 22 All primers were provided by Metabion. Data analysis. Spectratyping data were processed by GeneMarker Software V1.91 (SoftGenetics). For all PCR products of V␤and C␤-primers the peak intensities were plotted against the fragment lengths. Unskewed repertoires yield Gaussian length distributions with a high number of detectable peaks, while skewed repertoires show distortions with reduced numbers of fragment lengths. 23 An earlier study using capillary electrophoresis revealed maximum peak numbers between 9 and 13 for each individual of the 24 inspected V␤s 19 giving a total of 287 peaks, representing a theoretical complexity of 100%. The complexity score (CS) was calculated by quantifying the obtained peaks in every single V␤ of each sample and dividing the peak number through the theoretical maximum.
DNA sequencing. Single peaks in the spectratyping histograms of biopsy specimens representing monoclonal expansions were directly applied to sequencing (Seqlab, Germany) using the respective V␤ primer. In case of peripheral blood spectratyping, oligoclonal expansions were detected, thus, random cloning using a TA cloning kit pGEM-T (Promega) was required prior to sequencing.
Immunohistology. All stainings were performed on 10 m sural nerve cryosections. Immunohistochemistry was performed as previously described 24 using anti-CD8 (1:25, BD Biosciences). For immunofluorescence double-labeling, sections were postfixed in 4% paraformaldehyde and incubated in blocking solution. Sections were then incubated consecutively with anti-CD3 (Serotec, 1:100) or anti-CD8 (Abcam, 1:100) and anti-V␤5.1 (1:100, Beckman Coulter) or major histocompatibility complex (MHC) I (Abcam, 1:200). Secondary antibodies were Alexa goat anti-mouse Fluor 488 (1:100, Invitrogen) and goat anti-rabbit Cy3 (1:100, Dianova).
RESULTS T cells in inflammatory peripheral nerve infiltrates of patients with CIDP are clonally ex-
panded. To investigate the TCR repertoire of T-cell infiltrates in CIDP, we subjected sural nerve biopsy specimens of 25 patients with CIDP to CDR3 spectratyping analysis. As a positive control we used muscle biopsy samples from patients with inclusion body myositis (IBM, n ϭ 4), where lymphocytic infiltrates were shown to contain a restricted TCR repertoire, persisting over time. 25 As a negative control we used biopsy specimens from dermatomyositis (DM, n ϭ 6), known to be primarily mediated by the humoral immune system and lacking clonally expanded tissue T lymphocytes. 26 Additionally, nonpathologic control biopsy specimens (NPCB, n ϭ 3) were investigated. These patients had undergone nerve biopsy for diagnostic reasons, but showed normal morphology without inflammation. The CDR3 length repertoire of 24 TCR V␤s was investigated in each sample by performing fragment analysis to indicate clonally expanded T cells. A normally distributed CDR3 length repertoire contains all possible fragment lengths resulting in a complexity score of 100, whereas a restricted repertoire is characterized by shifts in the fragment length distribution, leading to a lower complexity score.
All CIDP nerve biopsy specimens showed strong restrictions in their TCR V␤ repertoire represented by monoclonal (single peaks in the histograms) and oligoclonal expansions (more than 1 detectable peak, but strongly deviating from a Gaussian distribution), a finding significantly differing from NPCBs and DM controls (mean CS CIDP Ϯ SD ϭ 26.9 Ϯ 8; figure 1 ). IBM samples showed a comparable pattern with a mean CS of 42.5 Ϯ 8.2 but a clearly higher rate of oligoclonal expansions. As expected, DM and NPCB samples mainly showed Gaussian distributed CDR3 fragment lengths resulting in a complexity score of 64.3 Ϯ 3.2 in the case of DM and 70 Ϯ 3.2 in the case of NPCB. Of note, dominant clonal expansions were not restricted to certain V␤ families (and found in all except V␤15; figure e-1).
CD8؉ T cells in the peripheral blood of patients with
CIDP show a restricted TCR V␤ repertoire. Next we assessed the TCR repertoire of CD4ϩ vs CD8ϩ T cells in the peripheral blood of patients with CIDP. Here, the cohort was narrowed to 12 patients where peripheral blood could be assessed in parallel to tissue specimens before the initiation of immune therapy to exclude possible alterations of the TCR repertoire due to immune-modulatory treatment. Strikingly, the peripheral CD8ϩ T-cell compartment showed strong oligoclonal expansions with a significantly restricted TCR V␤ repertoire. CD4 T cells were completely normally distributed. CD4ϩ and CD8ϩ T cells of age-and sex-matched healthy donors (HD, n ϭ 5) served as negative controls showing Gaussian distributed TCR repertoire (CIDP CD4 80.9 Ϯ 5.8, CIDP CD8 65.7 Ϯ 8.6, HD CD4 83.2 Ϯ 6.3, HD CD8 79.6 Ϯ 3.4) ( figure 2 ).
Nerve-infiltrating T-cell clones and peripheral CD8؉
T-cell V␤ expansions show sequence identity. In 7 out of the 12 peripheral blood CIDP samples, dominant peaks in the CD8ϩ T-cell compartment could be clearly assigned to the clonal expansions found in the corresponding nerve biopsy specimens (figure e-2). To prove that the CDR3 regions of the TCR V␤ chains in nerve biopsy and peripheral blood are identical, we used remaining RNA of the biopsy samples for direct CDR3 sequence analysis, where we could detect a clear CDR3 sequence of a monoclonal expansion. To match these sequences to the respective peripheral blood samples we had to perform random cloning since the blood histograms mainly showed oligoclonal or polyclonal expansions with several detectable fragment lengths (figure e-2). Figure 3 depicts matching clones in nerve biopsy specimens compared to peripheral blood CD8ϩ T-cell subset of 3 patients with CIDP (nos. 17, 20, 24; table e-1). This sequence comparison provides strong evidence that monoclonally expanded T cells found in the biopsy specimens are also found expanded in peripheral blood and, more importantly, belong to the CD8ϩ T-cell compartment. There were no matches between CD4ϩ T cells and DNA sequences from biopsies. and showed overlap with tissue TCR V␤ expansions. Together with the histopathologic evidence of the predominance of expanded clones in the nerve infiltrates, these findings support the hypothesis of a relevant antigen-driven MHC class I restricted, CD8ϩ T-cell-mediated attack against peripheral nerve tissue components contributing to the pathogenesis of CIDP. Clonal expansions in CIDP tissue specimens were unexpectedly strong, sometimes showing even monoclonal expansions. On a technical note, CDR3 spectratyping analysis predisposes for altered complexity scores with low numbers of analyzable T cells, e.g., in biopsy samples. A minimum of 50,000 T cells, each with an individual TCR composition (theoretical maximum in humans: 10 15 different TCR molecules 27 ), are needed to generate a Gaussian distributed TCR repertoire (unpublished observations). Nevertheless, we can exclude that this influences our data due to the significantly lower CIDP CS compared to NPCB biopsy CS (whereas T-cell counts in the biopsy: CIDP Ͼ NPCB). Accordingly, the IBM control, where an involvement of T cells in the pathogenesis is presumed, 28 showed oligoclonal expansions when compared with DM samples (T-cell counts in the biopsy: IBM Ͼ DM). 26 Importantly, clonal perturbations were consistently observed in peripheral blood of patients with CIDP (while absent in HD). Their clear restriction to CD8ϩ T cells and the overlap with expanded tissue clones strongly advocates a relevance of cytotoxic T cells in disease pathogenesis. Moreover, it raises the question where the main T-cell expansion occurs: whether the clones 1) enter the bloodstream after expansion at the site of inflammation or 2) expand in secondary lymphoid organs upon systemic antigen presentation subsequently invading peripheral nervous system tissue.
While a definitive answer is difficult to make, we clearly favor the second hypothesis since in situ expansion of clones in peripheral nerve 1) would lead to more pronounced T-cell infiltrates in CIDP biopsy tissue and 2) would make it difficult to detect circulating clones within the large pool of lymphocytes in peripheral blood.
The histopathologic demonstration of a major V␤5.1 expansion within tissue CD8 T cells in sample 20 visualizes the dominance of the antigen-driven infiltration of T cells in CIDP biopsies. This finding does not diminish the relevance of macrophages found in the biopsy infiltrates. 24 On the contrary, it allows for a hypothesis of combined immune pathophysiology, where patrolling CD8ϩ T cells, specific for an antigen present in the nervous tissue, initially attack nerve structures leading to a release of antigen to the periphery 29 and the formation of an inflamma- tory milieu. 30 Resident or attracted macrophages then exert major damage leading to demyelination of axonal structures. Additionally, they may act as antigen presenting cells for CD8ϩ T cells indicated by ICOS/ICOS-L upregulation on either cell type. 31 Schwann cells provide antigen presentation through MHC-I, but also MHC-II as CD4ϩ T cells express-ing CTLA-4 and CD28 were shown to reside in proximity to BB-1 expressing Schwann cells within the endoneurium 32 hinting at a contribution of CD4ϩ T cells in the pathology of CIDP. The antigens recognized by the expanded CD8ϩ T cells in CIDP are currently elusive. However, our findings are compatible with a viral or autoantigen as trigger or perpetuator of the disease. In line with the current literature, 16 neither a restricted V␤ usage nor public clones were found, excluding a superantigen as cause of the disease. Nevertheless, a common antigen cannot be excluded as patients with different HLA types can exhibit TCR expansions in different V␤s when exposed to the same antigen. Also different, possibly myelin-derived antigens could cause similar symptoms as parts of several CIDP cohorts were found to be seropositive for, i.e., P0, P2, or PMP2 (reviewed in 33 ). Furthermore, epitope spreading may occur immediately after the first events of antigen release leading to secondary clonal expansion of lymphocytes, possibly masking the initial and maybe causative T-cell clones. 33 Finally, molecular mimicry leading from an exogenous trigger to an autoimmune process is also conceivable. 5 Further studies focusing on longitudinal assessments to test for the persistence of potentially pathogenic CD8ϩ T-cell clones in combination with a broadened screening for antigens using these respective clones will contribute to the understanding and treatment of CIDP.
